"We are delighted that Dr. Fischbeck will be joining the NINDS intramural research program," said NINDS Scientific Director Story Landis, Ph.D. "The identification of genes responsible for neurological disorders has had a major impact on the understanding of pathogenesis and offers remarkable promise for the development of new therapies. Dr. Fischbeck has been a leader in this field from its inception and will significantly enhance our disease-related research programs. He will also be an invaluable bridge between the National Human Genome Research Institute and the NINDS."
Dr. Fischbeck received his undergraduate training at Harvard University and, in 1976, received his M.D. from The Johns Hopkins University. He completed additional training at Case Western Reserve University Hospital in Cleveland, the University of California at San Francisco, and the University of Pennsylvania School of Medicine in Philadelphia, where he currently serves on the faculty of medicine in the department of neurology.
As chief of the recently established NINDS Neurogenetics Branch, Dr. Fischbeck will oversee and coordinate all intramural research programs related to neurological disorders thought to have a genetic component. Although he will be based within the NINDS Division of Intramural Research, Dr. Fischbeck will hold a joint appointment with the National Human Genome Research Institute.
Dr. Fischbeck currently holds memberships in the American Academy of Neurology, the American Society of Human Genetics, the American Neurological Association, and the American Society for Clinical Investigation. In addition, he serves on the scientific advisory boards of a number of organizations, including those serving families and individuals affected by muscular dystrophy, neurofibromatosis, Charcot-Marie-Tooth disorder, ALS, spinal muscular atrophy, and Huntington's disease. Dr. Fischbeck has also received numerous professional awards.
The NINDS is the nation's principal supporter of research on the brain and nervous system. The Institute is also a lead agency for the Congressionally designated Decade of the Brain.